Day: April 29, 2020

RESEARCH TRIANGLE PARK, N.C., April 29, 2020 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity from cisplatin in pediatric cancer patients, today announced that it intends to offer its common shares in an underwritten public offering. In addition, Fennec intends to grant the underwriters a 30-day option to purchase up to an additional 15% of its common shares offered in the public offering.Cantor Fitzgerald & Co. is acting as the sole book-running manager for the proposed offering. Wedbush PacGrow is acting as the co-manager.The common shares are being offered by the Company pursuant to a registration statement previously filed with and...

FAIR LAWN, N.J., April 29, 2020 (GLOBE NEWSWIRE) — Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank (the “Bank”), reported net income of $6.8 million, or $0.06 per basic and diluted share, for the quarter ended March 31, 2020, as compared to net income of $14.9 million, or $0.13 per basic and diluted share, for the quarter ended March 31, 2019. The decrease in earnings for the quarter ended March 31, 2020 was mainly the result of a higher provision for loan losses driven primarily by increases to macro-economic qualitative factors impacted by the ongoing COVID-19 pandemic. The increase in the provision for loan losses coupled with an increase in non-interest expense was partially offset by an increase in net interest income driven by an increase in interest on loans...

NORTHLAKE, Texas, April 29, 2020 (GLOBE NEWSWIRE) — Farmer Bros. Co. (NASDAQ:FARM) (the “Company”) today announced that it has drawn down $34.0 million on its $125.0 million revolving credit facility, bringing the total amount outstanding to $122.0 million of revolving loans and $2.3 million of outstanding letters of credit. This is a proactive measure to increase the Company’s cash position and preserve financial flexibility.Deverl Maserang, President and Chief Executive Officer of Farmer Brothers, said, “We remain focused on taking actions to support the long-term sustainability of our business as we continue to navigate the evolving COVID-19 situation. In addition to the steps we have already taken to eliminate discretionary expenses and reduce capital expenditures, we are accessing additional funds through our credit facility...

CALGARY, Alberta, April 29, 2020 (GLOBE NEWSWIRE) — Northview Apartment Real Estate Investment Trust (“Northview” or “the REIT”) (TSX:NVU.UN) today announced the filing of a management information circular in connection with the previously announced arrangement agreement (the “Arrangement”) with affiliates of Starlight Group Property Holdings Inc. (“Starlight”) and KingSett Capital Inc. (“KingSett”) (collectively, the “Purchasers”), pursuant to which the Purchasers will acquire Northview and the holders of Northview’s outstanding trust units (“Units”) (other than Starlight’s interest in the REIT which will be rolled into the acquiring entities) will receive $36.25 per Unit (the “Transaction”), payable, at the election of Unitholders, in cash, in a combination of cash and units of a new multi-residential fund (the “High Yield Fund”),...

Boliga Gruppen A/S: Tilrettet forløb af ordinær generalforsamling 2020Boliga Gruppen A/SCVR nr. 25 07 87 80(“Selskabet“)Fondsbørsmeddelelse nr. 6/2020Vedhæftet er tilrettet forløb af ordinær generalforsamling vedrørende dagsordenens punkt 2 og spørgsmål nr. 4 stillet af aktionær.Punkt 2 er ændret til følgende:”Forelæggelse af årsrapport til godkendelseSelskabets CFO, Mikkel C. Hesselberg, fremlagde Selskabets årsrapport for 2019 og forelagde årsrapporten til godkendelse.Årsrapporten blev godkendt med 11.747.004 stemmer for, mens 286.400 stemmer undlod at stemme.”Spørgsmål 4 er tilføjet og besvaret sammen med spørgsmål 5.”Spørgsmål 4 og 5 blev besvaret samlet på generalforsamlingen:Spørgsmål 4: Forventer bestyrelsen nye omsætningskilder relateret til boligportaler, som ikke er kendt for aktiemarkedet?Spørgsmål 5: Kan bestyrelsen...

Millicom refutes Telefónica’s claim over Costa Rica purchase agreementLuxembourg, April 29, 2020 – Millicom International Cellular S.A. refutes Telefonica’s recent public communications alleging that the conditions to closing the Share Purchase Agreement (SPA) for the acquisition of Telefónica’s operating subsidiary in Costa Rica have been met.  Millicom further notes that, in the event that the pending regulatory approvals for the transaction are not issued by May 1, 2020, it intends to terminate the SPA in accordance with the terms of the agreement.As communicated in the press release dated February 20, 2019, Millicom entered into the SPA on that date to acquire Telefonica’s Costa Rica mobile business subject to customary closing conditions, which included the issuance of required regulatory approvals, certain of which have not yet...

RÉSULTATS DU PREMIER TRIMESTRE 2020Communiqué de presseParis, le 29 avril 2020Le Groupe informe le public que Société Générale publiera ses résultats du premier trimestre 2020 le jeudi 30 avril 2020 avant l’ouverture des marchés.Contacts presse :Corentin Henry _ +33 1 58 98 01 75 _ corentin.henry@socgen.com@SG_presseSociété GénéraleSociété Générale est l’un des tout premiers groupes européens de services financiers. S’appuyant sur un modèle diversifié et intégré, le Groupe allie solidité financière, dynamique d’innovation et stratégie de croissance durable et responsable. Engagée dans les transformations positives des sociétés et des économies, Société Générale agit chaque jour avec ses équipes pour construire ensemble, avec ses clients, un avenir meilleur et durable en apportant des solutions financières responsables et innovantes.Acteur...

FIRST QUARTER 2020 RESULTSPress releaseParis, 29 April 2020The Group informs the public that Societe Generale will release its first quarter 2020 results on Thursday 30 April 2020 before market opening.Press contacts:Corentin Henry _ +33 1 58 98 01 75 _ corentin.henry@socgen.com@SG_presseSociete GeneraleSociete Generale is one of the leading European financial services groups. Based on a diversified and integrated banking model, the Group combines financial strength and proven expertise in innovation with a strategy of sustainable growth. Committed to the positive transformations of the world’s societies and economies, Societe Generale and its teams seek to build, day after day, together with its clients, a better and sustainable future through responsible and innovative financial solutions.Active in the real economy for over 150 years,...

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received a No Objection Letter from Health Canada to proceed with a NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory authorities.“The study is an adaptive pilot to pivotal trial design based on guidance documents from the World Health Organization (WHO) to determine if Ifenprodil can improve clinical symptoms of COVID-19 by reducing the number of COVID-19 diagnosed patients from progressing to mechanical ventilation with intubation and death.” said Dr. Mark William’s,...

Media ReleaseSix industry sponsored abstracts regarding Genmab and Genmab partnered programs selected for presentation at ASCO20 Virtual Scientific Program, including data from the epcoritamab (DuoBody®-CD3xCD20) Ph I/II dose-escalation study.Genmab A/S (Nasdaq: GMAB) announced today that six industry sponsored abstracts regarding Genmab and Genmab partnered programs were accepted for presentation at the American Society of Clinical Oncology 2020 (ASCO20) Virtual Scientific Program, taking place from May 29 to 31, 2020. The titles of the abstracts are currently available on the ASCO Meeting Library, with the full abstracts scheduled to be published on May 13, 2020. A list of the abstracts is provided below, and includes one on epcoritamab, one on tisotumab vedotin (Trial in Progress) and four on daratumumab. Beginning Friday, May 29,...